Assessment of Safety, Efficacy and Predictability of a Trifocal Intraocular Lens. Performance of PanOptix Trifocal Versus Monofocal IOL

Purpose. To evaluate the performance and the visual outcomes of Acrysof PanOptix trifocal IOL in terms of safety, efficacy, predictability and assessment of the quality of vision after implantation as regards; contrast sensitivity and ocular aberrations. Methods. A prospective interventional non randomized study that included forty eyes of twenty one patients with senile cataract. All surgeries were carried out between September 2019 and January 2020. Patients underwent phacoemulsification for cataract removal with IOL implantation. They were divided into two groups; group(A) included twenty eyes of eleven patients who were implanted with AcrySof IQ PanOptix trifocal IOL Model TFNT00. While group (B) included twenty eyes of ten patients who were implanted with monofocal AcrySof IOLs as a control group. Results. There were 21 subjects enrolled in our study. Mean age was 56.6 ± 6.9 years in group (A) and 62.8 ± 7.1 years in group (B),(range 50–70).We found statistical significant difference between both groups with group A showing better post operative uncorrected distance, intermediate, near, and best corrected near visual acuity . Group (B) showed statistically significant better post operative contrast sensitivity compared to group (A). Conclusion: In this study, Acrysof PanOptix trifocal IOL showed excellent safety, efficacy, predictability and spectacle independence at all distances, This prospective interventional non-randomized study showed excellent safety, efficacy and predictability of the PanOptix IOL with higher spectacle independence, slightly impaired contrast sensitivity without affecting daily activities. However, contrast sensitivity was compromised in comparison to the monofocal group and high order aberrations (coma, trefoil) were noted to be higher affecting the quality of vision but not the daily activities of the patient.

1. Alió JL, Plaza-Puche AB, Férnandez-Buenaga R. Multifocal intraocular lenses: an overview. Surv Ophthalmol. 2017; 62: 611–634. doi: 10.1016/j.survophthal.2017.03.005.

2. Lawless M, Hodge C, Reich J. Visual and refractive outcomes following implantation of a new trifocal intraocular. Eye Vis. 2017;4: 10. doi: 10.1186/s40662-0170076-8. eCollection 2017.

3. García-Pérez JL, Gros-Otero J, Sánchez-Ramos C. Short term visual outcomes of a new trifocal intraocular. BMC Ophthalmol. 2017;17:72. doi: 10.1186/s12886-0170462-y.

4. Lee S, Choi M, Xu Z, Zhao Z, Alexander E, Liu Y. Optical bench performance of a novel trifocal intraocular lens compared with a multifocal intraocular lens. Clin Ophthalmol. 2016;10:1031–1038. doi: 10.2147/OPTH.S106646. eCollection 2016.

5. Sudhir RR, Dey A, Bhattacharrya S, Bahulayan A. AcrySof IQ PanOptix Intraocular Lens Versus Extended Depth of Focus Intraocular Lens and trifocal Intraocular Lens: A Clinical Overview. Asia Pac J Ophthalmol (Phila). 2019;8(4):335–349. doi: 10.1097/APO.0000000000000253.

6. Knapp S, Awwad ST, Ghali C, McCulley JP. Ocular aberrations measured by the Fourier based WaveScan and Zernike based Ladar Wave Hartmann-Shack aberrometers. J Refract Surg.2009;25(2): 201–209. doi: 10.3928/1081597X20090201-05.

7. Alió JL, Plaza-Puche AB, Sala E. Impact of low mesopic contrast sensitivity outcomes in different types of modern multifocal intraocular lenses. Eur J Ophthalmol.2016;26:612–617. doi: 10.5301/ejo.5000777.

8. Alió JL, Plaza-Puche AB, Alio Del Barrio JL. Clinical outcomes with a diffractive trifocal intraocular lens. Eur J Ophthalmol. 2018; 28:419–424. doi: 10.1177/1120672118762231.

9. Kohnen T, Herzog M, Hemkeppler E. Visual performance of a quadrifocal (trifocal) intraocular lens following removal of the crystalline lens. Am J Ophthalmol. 2017;184:52–62. doi: 10.1016/j.ajo.2017.09.016.

10. García-Pérez JL, Gros-Otero J, Sanchez-Ramos C. Short term visual outcomes of a new trifocal intraocular lens. BMC Ophthalmol.2017;17:72. doi: 10.1186/s12886017-0462-y.

11. Lawless M, Hodge C, Reich J. Visual and refractive outcomes following implantation of a new trifocal intraocular lens. Eye Vis (Lond). 2017;4:10.

12. Gundersen k, Potvin R. Trifocal intraocular lenses: a comparison of the visual performance and quality of vision provided by two different lens designs. Clin.Ophthalmology. 2017;11:1081–1087. doi: 10.1186/s40662-017-0076-8.

13. Mencucci R, Favuzza E, Caporossi O. Comparative analysis of visual outcomes, reading skills, contrast sensitivity, and patient satisfaction with two models of trifocal diffractive intraocular lenses and an extended range of vision intraocular lens. Graefes Arch ClinExpOphthalmol .2018;256:1913–1922. doi: 10.1007/s00417-018-4052-3.

14. Cochener B, Boutillie G, Lamar M. A comparative evaluation of a new generation of diffractive trifocal and extended depth of focus intraocular lenses. J Refract Surg 2018;34:507–514. doi: 10.3928/1081597X-20180530-02.

15. Sheppard AL, Shah S, Bhatt U. Visual outcomes and subjective experience after bilateral implantation of a new diffractive trifocal intraocular lens. J Cataract Refract Surg 2013; 39: 343–349. doi: 10.1016/j.jcrs.2012.09.017.

16. Applegate RA, Sarver EJ, Khemsara V. Are all aberrations equal? J Refract Surg 2002;18: S556–S562. doi: 10.3928/1081-597X-20020901-12.

17. Chung SH, Kim TI, Cho YJ, Yoon G, SeoKY.Comparison of higher order aberration and contrast sensitivity in monofocal and multifocal intraocular lenses. Yonsei Med J. 2007;48(4):627–633. doi: 10.3349/ymj.2007.48.4.627.

18. Davison JA. Neodymium: YAG laser posterior capsulotomy after implantation of AcrySof intraocular lenses. J Cataract Refract Surg. 2004;30:1492–1500. doi: 10.1016/j.jcrs.2003.11.042.

19. Kacerovsky M. PanOptix and AT LISA tri in presbyopic surgery. Presented at European Socitey of Cataract and Refractive Surgeons education forum. September 2018, Vienna, Austria.